載入...
Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
BACKGROUND: Nearly 85 % of lung-cancer-specific epidermal growth factor receptor (EGFR) sensitive mutations comprise a substitution at position 858 (21L858R) and deletion mutants in exon 19 (19del). The aim of this study was to assess the role of EGFR mutation subtypes in predicting the efficacy of...
| Autores principales: | , , , , , , |
|---|---|
| 格式: | Online Artículo Texto |
| 語言: | English |
| 出版: |
Springer Berlin Heidelberg
2014
|
| 主題: | |
| 在線閱讀: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196046/ https://www.ncbi.nlm.nih.gov/pubmed/24908327 http://dx.doi.org/10.1007/s00432-014-1709-0 |